Citation Impact
Citing Papers
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies
2014
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies
2003
Applications of novel drug delivery system for herbal formulations
2010 Standout
Gastrointestinal health and function in weaned pigs: a review of feeding strategies to control post‐weaning diarrhoea without using in‐feed antimicrobial compounds
2012 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Instability, stabilization, and formulation of liquid protein pharmaceuticals
1999 Standout
Dietary supplementation with phosphorylated mannans improves growth response and modulates immune function of weanling pigs1
2004
Effect of phosphorylated mannans and pharmacological additions of zinc oxide on growth and immunocompetence of weanling pigs
2004
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
2018 StandoutNobel
Interleukin-2 Activity Can Be Fine Tuned with Engineered Receptor Signaling Clamps
2015
A general approach to the synthesis ofO- andN-linked glycopeptides
1994 StandoutNobel
Protein glycosylation
1993
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Regulation of IgA synthesis and immune response by T cells and interleukins
1989
Fcγ receptors as regulators of immune responses
2007 Standout
Biological roles of glycans
2016 Standout
Biology of Natural Killer Cells
1989 Standout
Liposomes as targeted drug delivery systems in the treatment of breast cancer
2006
Carbonoyloxy analogs of the anti-metastatic drug swainsonine
1993
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
2013
Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function.
1988
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
Cytokines in Cancer Immunotherapy
2017
Nutritional management of gut health in pigs around weaning
2007 Standout
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life
2019
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Structure of the decoy module of human glycoprotein 2 and uromodulin and its interaction with bacterial adhesin FimH
2022 StandoutNobel
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
1999
Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines
2001
Platelet Activation and Binding of Complement Components to Platelets Induced by Immune Complexes
1994 StandoutNobel
Indolizidine and quinolizidine alkaloids
2004 Standout
Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein
1999
TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties
1989 Standout
Functional Roles of the IgM Fc Receptor in the Immune System
2019 StandoutNobel
Synthesis of the glycosyl amino acids p-(1 → 3)- p]- p-(1 → 3)- p]- and the application in the solid-phase peptide synthesis of multiply glycosylated mucin peptides with Tn and T antigenic structures
1995 StandoutNobel
Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells
1998
Molecular Basis of Fc Receptor Function
1994
Interferon-γ: an overview of signals, mechanisms and functions
2003 Standout
5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
2002
A Strategy for the Chemoselective Synthesis of O-Linked Glycopeptides with Native Sugar−Peptide Linkages
1997 StandoutNobel
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia
2010
Effect of phosphorylated mannans and pharmacological additions of zinc oxide on growth and immunocompetence of weanling pigs
2004
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
2004 StandoutNobel
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
IgA Fc Receptors
2003
The experimental histopathology of Lernaea polymorpha Yu, 1938 infection in naive Aristichthys nobilis (Richardson) and a comparison with the lesion in naturally infected clinically resistant fish
1989 StandoutNobel
Morphological aspects of T cell subpopulations in human blood: characterization of the cerebriform mononuclear cells in healthy individuals.
1981
Inhibitors of carbohydrate processing: A new class of anticancer agents.
1995
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
METABOLIC SUBSTRATE ENGINEERING AS A TOOL FOR GLYCOBIOLOGY
2002 StandoutNobel
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
1997 Standout
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia
1994 StandoutNobel
Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.
2001
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Fmoc-Based Synthesis of Peptide-αThioesters: Application to the Total Chemical Synthesis of a Glycoprotein by Native Chemical Ligation
1999 StandoutNobel
Lymphocytes with Immunoglobulin E Fc Receptors in Patients with Atopic Disorders
1979
Immunopathology of parasitic diseases: Involvement of basophils and mast cells
1980
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Solid-phase synthesis of a fucosylated glycopeptide of human factor IX with a fucose-α-(1→O)-serine linkage
1995 StandoutNobel
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
The Biology and Detection of Immune Complexes
1980
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2008 Standout
Cytokine production in the immune response to murine gammaherpesvirus 68
1996 StandoutNobel
Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins.
1987 StandoutNobel
Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.
2001
Efficient Identification of Novel Hla-A*0201–Presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen Prame by Proteasome-Mediated Digestion Analysis
2001
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Jean Decker being referenced
Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?
1998
Absence of point mutations in the extracellular domain of the alpha subunit of the GM-CSF receptor in a series of patients with acute myeloid leukemia (AML).
1995
Evidence That Specific High-Mannose Oligosaccharides Can Directly Inhibit Antigen-Driven T-Cell Responses
1990
A Receptor for IgA on Human T Lymphocytes
1979
Phase 1 trial of IL-15 trans presentation blockade using humanized Mik-Beta-1 mAb in patients with T-cell large granular lymphocytic leukemia
2012
Evidence that high mannose glycopeptides are able to functionally interact with recombinant tumor necrosis factor and recombinant interleukin 1.
1990